OAS1、OAS2和OAS3通过调控细胞周期并增强IFN-1诱导的Jak1-STAT1磷酸化促进银屑病表皮角质形成细胞增殖
本研究探讨2'-5'-寡腺苷酸合成酶(OAS)家族在银屑病中的作用。发现OAS1、OAS2、OAS3在银屑病皮损皮肤和血清中过表达,且被生物制剂下调;在表皮角质形成细胞中经poly(I:C)、poly(dA:dT)和IFN-1s上调、Jak抑制剂下调;沉默OAS可抑制Jak1和STAT1磷酸化,并通过抑制细胞周期进程抑制角质形成细胞增殖。提示OAS可能为银屑病治疗生物标志物。
要点
- OAS1、OAS2、OAS3在银屑病皮损皮肤和血清中过表达,且被生物制剂下调。
- OAS在表皮角质形成细胞中经poly(I:C)、poly(dA:dT)和IFN-1s上调,经Jak抑制剂下调。
- 沉默OAS抑制Jak1和STAT1磷酸化,并通过抑制细胞周期进程抑制角质形成细胞增殖。
核心结论
- OAS1、OAS2和OAS3可能通过调控细胞周期并增强IFN-1诱导的Jak1-STAT1磷酸化促进银屑病表皮角质形成细胞增殖,可能为银屑病治疗生物标志物。
研究设计与样本
- 研究检测了人银屑病皮损皮肤和血清中OAS1、OAS2、OAS3的表达,并用流式细胞术分析其细胞来源,在正常人表皮角质形成细胞中进行调控实验和沉默实验。
主要发现
- OAS1、OAS2、OAS3在银屑病皮损皮肤和血清中过表达,且其表达被生物制剂下调。
- OAS高表达于银屑病表皮和真皮中的表皮角质形成细胞、表皮树突状细胞、表皮CD3+ T细胞、真皮抗原呈递细胞和真皮T细胞。
- 在正常人表皮角质形成细胞中,OAS被poly(I:C)、poly(dA:dT)和IFN-1s上调,被Jak抑制剂下调。
- 沉默OAS抑制Jak1和信号转导及转录激活因子1的磷酸化。
- 敲低OAS通过抑制细胞周期进程抑制角质形成细胞增殖。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psoriasis is a systemic immune‒mediated inflammatory disease characterized by hyperproliferation and abnormal differentiation of epidermal keratinocytes. Recent studies have identified IL-17 and IL-23 as key drivers of psoriasis pathogenesis, but the underlying molecular mechanisms remain unclear. The 2'-5'-oligoadenylate synthetases (OASs), namely, OAS1, OAS2, OAS3, and OASL, are a family of IFN-induced enzymes with multiple antiviral activities, but their role in psoriasis is unknown. In this study, we identified the overexpression of OAS1, OAS2, and OAS3 in human lesional psoriatic skin and serum and found that their expression was downregulated by biologics. Moreover, OASs were highly expressed in epidermal keratinocytes, epidermal dendritic cells, epidermal CD3+ T cells, dermal antigen-presenting cells, and dermal T cells from the psoriatic epidermis and dermis, as determined by flow cytometry. In addition, OASs were upregulated by poly(I:C), poly(dA:dT), and IFN-1s but downregulated by Jak inhibitors in normal human epidermal keratinocytes. Furthermore, silencing of OASs inhibited the phosphorylation of Jak1 and signal transducer and activator of transcription 1. Knockdown of OASs suppressed keratinocyte proliferation by inhibiting cell cycle progression. Thus, OASs may be therapeutic biomarkers in psoriasis.
引用
- Huang YZ, Zheng YX, Zhou Y, et al. OAS1, OAS2, and OAS3 Contribute to Epidermal Keratinocyte Proliferation by Regulating Cell Cycle and Augmenting IFN-1‒Induced Jak1‒Signal Transducer and Activator of Transcription 1 Phosphorylation in Psoriasis. J Invest Dermatol. 2022. PMID: 35305973. doi:10.1016/j.jid.2022.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。